NPI: 1629218185 · SPARKS, NV 89434 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/24/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/24/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,031 | $293K |
| 2019 | 14,850 | $294K |
| 2020 | 17,613 | $422K |
| 2021 | 18,221 | $472K |
| 2022 | 20,713 | $462K |
| 2023 | 18,759 | $494K |
| 2024 | 8,047 | $459K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 47,822 | 2,227 | $2.89M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,480 | 1,007 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,635 | 831 | $139.32 |
| G0008 | Administration of influenza virus vaccine | 137 | 69 | $49.62 |
| 90661 | 18 | 18 | $36.85 | |
| 83970 | 1,627 | 708 | $0.00 | |
| 85041 | 2,565 | 1,128 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 8,056 | 1,269 | $0.00 |
| 83540 | 1,130 | 501 | $0.00 | |
| 85048 | 2,534 | 1,115 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 354 | 167 | $0.00 |
| 85045 | 596 | 213 | $0.00 | |
| 82108 | 135 | 58 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 3,955 | 1,322 | $0.00 |
| 82728 | 1,116 | 502 | $0.00 | |
| 83550 | 599 | 312 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 326 | 71 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 149 | 70 | $0.00 |